Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pavmed (PAVM)
:PAVM
Holding PAVM?
Track your performance easily
Earnings Data
Report Date
Apr 01, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.11Last Year’s EPS
-2.62Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 15, 2018
|% Change Since: -36.27%
|Next Earnings Date:Aug 14, 2018
Earnings Call Sentiment|Positive
The earnings call reflected a positive sentiment with significant achievements in revenue growth, strategic restructuring, and partnership developments. However, there were challenges related to delayed financing and NASDAQ compliance, which were addressed with strategic initiatives.Company Guidance
During the PAVmed Q3 2024 earnings call, the company provided several key metrics and updates. PAVmed reported a 20% quarter-on-quarter revenue increase for its subsidiary, Lucid Diagnostics, and a significant financial restructuring that preserved its NASDAQ listing by maintaining a GAAP stockholders' equity greater than $2.5 million, beginning from a deficit of $18.6 million as of June 30. The company also highlighted a deconsolidation of Lucid Diagnostics from PAVmed, reducing shareholder deficit by half, and an agreement to exchange $25 million of convertible debt for Series C convertible preferred stock, thus positioning PAVmed for sustained NASDAQ compliance. Additionally, PAVmed's Veris Health subsidiary received a $1.8 million NIH grant and completed a successful pilot with The Ohio State University's James Cancer Center. Overall, PAVmed's strategic transformation positions it as a diversified commercial life sciences company, with planned developments like the PortIO device and the Veris Cancer Care Platform marking its future growth trajectory.Record Revenue Growth
PAVmed reported record revenue in the third quarter, with an increase of 20% quarter-on-quarter. This marks a significant achievement in the company's financial performance.
Strategic Corporate Restructuring
PAVmed successfully deconsolidated Lucid Diagnostics, preserving ownership without absorbing operating losses, and restructured convertible debt, allowing the company to maintain its NASDAQ listing.
Veris Health and NIH Grant
Veris Health received a $1.8 million NIH grant to optimize its Cancer Care Platform for underserved patients, marking a significant development in personalized cancer care.
Ohio State University Pilot Success
The Veris Health pilot with The Ohio State University was completed successfully, leading to discussions on long-term partnerships and serving as a template for future collaborations.
Positive Financial Positioning
PAVmed reported a breakeven scenario on a stand-alone basis for the third quarter after adjustments, showing financial stability post-restructuring.
---
PAVM Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
PAVM Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 14, 2024 | $1.02 | $1.09 | +6.86% |
| Aug 13, 2024 | $0.80 | $0.74 | -7.50% |
| May 14, 2024 | $1.92 | $2.22 | +15.63% |
| Mar 26, 2024 | $2.06 | $2.73 | +32.52% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Pavmed (PAVM) report earnings?
Pavmed (PAVM) is schdueled to report earning on Apr 01, 2025, TBA Not Confirmed.
What is Pavmed (PAVM) earnings time?
Pavmed (PAVM) earnings time is at Apr 01, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PAVM EPS forecast?
PAVM EPS forecast for the fiscal quarter 2024 (Q4) is -0.11.
---